Long-Term Safety and Efficacy Data Supporting AP01 (Inhaled Pirfenidone) from the ATLAS Open-Label Extension Trial to be ...

Findings and insights related to nursing and virtual reality, AI and infusions were just some of the topics covered at the ...

In addition to the presentations, Viral Kansara, PhD, Vice President, Preclinical Development moderated an ARVO session entitled "Retina/RPE: New drugs, mechanisms of action, and toxicity” and Dr.

Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have ...

Premeds can get an edge by being published several ways, from hypothesis-based research papers to conference abstracts.

Topical BRAF inhibitor LUT014 gel significantly reduces acneiform rash from anti-EGFR therapies in patients with colorectal ...

The company announced 27 abstracts at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting ...

The first day will kick off with a keynote presentation by Jennifer Willert, Global Clinical Development Medical Director of Novartis Cell and Gene Therapy and Hematology, focusing on the learnings ...

Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic ...